Accessibility Menu
Biote Stock Quote

Biote (NASDAQ: BTMD)

$2.89
(-1.4%)
-0.04
Price as of November 6, 2025, 1:35 p.m. ET

KEY DATA POINTS

Current Price
$2.89
Daily Change
(-1.4%) $0.04
Day's Range
$2.86 - $2.98
Previous Close
$2.93
Open
$2.98
Beta
0
Volume
52,420
Average Volume
152,488
Market Cap
97.5M
Market Cap / Employee
$2.93M
52wk Range
$2.65 - $6.98
Revenue
-
Gross Margin
0.70%
Dividend Yield
N/A
EPS
$0.90
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Biote Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BTMD-43.87%N/AN/A-71%
S&P+17.53%+93.66%+14.13%+62%

Biote Company Info

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

News & Analysis

No results found

No news articles found for Biote.

Financial Health

General

Q2 2025YOY Change
Revenue$48.86M-0.6%
Gross Profit$34.14M3.4%
Gross Margin69.86%2.7%
Market Cap$132.95M-41.3%
Market Cap / Employee$0.61M0.0%
Employees21711.9%
Net Income$3.93M137.5%
EBITDA$12.48M66.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$19.60M-25.8%
Accounts Receivable$9.08M17.9%
Inventory16.2-31.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$119.03M2.9%
Short Term Debt$34.64M419.4%

Ratios

Q2 2025YOY Change
Return On Assets31.67%25.7%
Return On Invested Capital38.94%-10.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$5.28M-29.1%
Operating Free Cash Flow$7.09M-28.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings27.5034.315.454.45-93.22%
Price to Book-1.33-1.48-0.99-1.41-80.43%
Price to Sales0.931.170.620.64-51.42%
Price to Tangible Book Value-1.19-1.31-0.87-1.21-75.37%
Price to Free Cash Flow TTM6.116.763.893.90-76.90%
Enterprise Value to EBITDA19.4332.9023.5121.47-53.31%
Free Cash Flow Yield16.4%14.8%25.7%25.6%332.85%
Total Debt$122.31M$179.74M$179.32M$153.67M25.57%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.